Lord, Abbett & Co. LLC Intellia Therapeutics, Inc. Transaction History

Lord, Abbett & Co. LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$38.49 - $76.21 $486,860 - $963,980	12,649 Added 3.49%	375,399 $19.4 Million
Q1 2022 May 13, 2022	SELL	$58.27 - $118.99 $34 Million - $69.5 Million	-584,084 Reduced 61.69%	362,750 $26.4 Million
Q4 2021 Feb 11, 2022	SELL	$100.76 - $138.36 $10.5 Million - $14.4 Million	-103,965 Reduced 9.89%	946,834 $112 Million
Q3 2021 Nov 09, 2021	BUY	$132.37 - $176.78 $21.2 Million - $28.3 Million	159,899 Added 17.95%	1,050,799 $141 Million
Q2 2021 Aug 11, 2021	BUY	$60.88 - $161.91 $12.9 Million - $34.3 Million	211,759 Added 31.18%	890,900 $144 Million
Q1 2021 May 11, 2021	BUY	$46.59 - $83.68 $31.6 Million - $56.8 Million	679,141 New	679,141 $54.5 Million
Q4 2019 Feb 14, 2020	SELL	$10.43 - $17.67 $2.77 Million - $4.69 Million	-265,382 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$13.07 - $18.51 $234,005 - $331,403	-17,904 Reduced 6.32%	265,382 $3.54 Million
Q2 2019 Aug 14, 2019	SELL	$13.88 - $18.41 $1.05 Million - $1.39 Million	-75,742 Reduced 21.1%	283,286 $4.64 Million
Q1 2019 May 15, 2019	BUY	$12.79 - $17.62 $1.39 Million - $1.92 Million	108,825 Added 43.49%	359,028 $6.13 Million
Q4 2018 Feb 14, 2019	BUY	$11.39 - $27.13 $969,562 - $2.31 Million	85,124 Added 51.57%	250,203 $3.42 Million
Q3 2018 Nov 14, 2018	BUY	$25.78 - $32.6 $4.26 Million - $5.38 Million	165,079 New	165,079 $4.73 Million

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $775M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.